Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 21, 2015 4:08 PM ET

Life Sciences Tools and Services

Company Overview of Trino Therapeutics Ltd.

Company Overview

Trino Therapeutics Ltd., a drug discovery and early drug development company, focuses on anti-inflammatory therapeutics. It develops drug candidates from drugs based on indane dimers derived from a Taiwanese fern. The company’s lead candidate is a potential drug for the treatment of inflammatory bowel disease, which could be used in ulcerative colitis and Crohn’s disease. Its drugs also offer candidates for applications in dermatology, pulmonary, and auto-immune diseases. Trino Therapeutics Ltd. was formerly known as Pharmatrin Ltd. The company was founded in 1999 and is based in Dublin, Ireland.

The Tower

Trinity Technology and Enterprise Campus

Pearse Street

Dublin,  2

Ireland

Founded in 1999

Phone:

353 1 670 9865

Key Executives for Trino Therapeutics Ltd.

Chief Executive Officer
Co-Founder, Managing Director, Director and Member of Clinical & Scientific Advisory Board
Co-Founder, Principal Chemist, Director and Member of Clinical and Scientific Advisory Board
Chief Financial Officer
Head of Product Development
Compensation as of Fiscal Year 2014.

Trino Therapeutics Ltd. Key Developments

Trino Therapeutics Announces Management Appointments

Trino Therapeutics announced the appointments of Richard Davis, PhD., to the newly created position of chief executive officer. It also appointed Marie Lindner, MD., as a non-executive director to the Board of Directors. Dr. Davis joins from Wellcome Trusts Investment Division, where he managed direct investments in private and public pharmaceutical and life science companies, as well as those in sector-focused venture capital and private equity funds. Dr. Marie Lindner joined the Trino Board as a Non-Executive Director in March 2014. A distinguished medical gastroenterologist, Dr. Lindner is currently Global Program Head, Strategic Partnership Team at Novartis.

Similar Private Companies By Industry

Company Name Region
Venn Life Sciences Limited Europe
GenCell Biosystems Ltd. Europe
Alinicle Limited Europe
Life Scientific Ltd. Europe
Quintiles Ireland Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Trino Therapeutics Ltd., please visit www.trinotherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.